NO763345L - - Google Patents

Info

Publication number
NO763345L
NO763345L NO763345A NO763345A NO763345L NO 763345 L NO763345 L NO 763345L NO 763345 A NO763345 A NO 763345A NO 763345 A NO763345 A NO 763345A NO 763345 L NO763345 L NO 763345L
Authority
NO
Norway
Prior art keywords
compound
stated
formula
atoms
physiological salts
Prior art date
Application number
NO763345A
Other languages
English (en)
Norwegian (no)
Inventor
L A Svensson
L M Soerenby
K I L Wetterlin
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO763345L publication Critical patent/NO763345L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO763345A 1975-10-01 1976-09-30 NO763345L (en))

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
NO763345L true NO763345L (en)) 1977-04-04

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO763345A NO763345L (en)) 1975-10-01 1976-09-30

Country Status (19)

Country Link
JP (1) JPS5242840A (en))
AT (1) AT347427B (en))
AU (1) AU503212B2 (en))
BE (1) BE846837A (en))
CS (2) CS199644B2 (en))
DD (1) DD126278A5 (en))
DE (1) DE2640972A1 (en))
DK (1) DK141622B (en))
ES (1) ES451979A1 (en))
FI (1) FI762660A7 (en))
FR (1) FR2326183A1 (en))
GB (1) GB1542317A (en))
LU (1) LU75916A1 (en))
NL (1) NL7610845A (en))
NO (1) NO763345L (en))
NZ (1) NZ182165A (en))
SE (1) SE7510988L (en))
SU (2) SU638252A3 (en))
ZA (1) ZA765331B (en))

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
NZ324453A (en) * 1995-12-28 2000-03-27 Yoshitomi Pharmaceutical 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for topical administration in order to inhibit rejection reactions at organ or bone marrow transplantation or treating autoimmune disease
CA2529401C (en) 2003-06-17 2015-04-28 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
EP2471779A1 (en) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
AU2011296014A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
EP2939677A1 (en) 2010-09-01 2015-11-04 Arena Pharmaceuticals, Inc. Administration of lorcaserin to indviduals with renal impairment
SG188361A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
AR088670A1 (es) 2012-10-09 2014-06-25 Arena Pharm Inc Metodo de control del peso

Also Published As

Publication number Publication date
GB1542317A (en) 1979-03-14
AT347427B (de) 1978-12-27
DE2640972A1 (de) 1977-04-14
JPS5242840A (en) 1977-04-04
SU638252A3 (ru) 1978-12-15
DK439776A (en)) 1977-04-02
NL7610845A (nl) 1977-04-05
FI762660A7 (en)) 1977-04-02
ATA682376A (de) 1978-05-15
DD126278A5 (en)) 1977-07-06
SU674669A3 (ru) 1979-07-15
CS199644B2 (en) 1980-07-31
DK141622B (da) 1980-05-12
NZ182165A (en) 1978-07-10
LU75916A1 (en)) 1978-05-16
SE7510988L (sv) 1977-04-02
ZA765331B (en) 1977-08-31
BE846837A (fr) 1977-04-01
ES451979A1 (es) 1978-01-01
FR2326183A1 (fr) 1977-04-29
AU1812276A (en) 1978-04-06
AU503212B2 (en) 1979-08-30
CS199643B2 (en) 1980-07-31

Similar Documents

Publication Publication Date Title
NO152130B (no) Analogifremgangsmaate for fremstilling av bronchospasmolytisk virksomme forbindelser
NO763345L (en))
US4011258A (en) Orally active bronchospasmolytic compounds
EP0011609B2 (en) Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease
EP0001735B1 (en) Xanthine derivatives having antiallergic activity and pharmacological preparations containing them
EP0888313A1 (de) 2,3-benzodiazepinderivate und deren verwendung als ampa-rezeptoren-hemmer
DE2711981C2 (de) Phenäthylamin-Derivate und diese Verbindungen enthaltende bronchodilatorisch wirksame Mittel
DE2924880A1 (de) 2-aminooctahydroindolo eckige klammer auf 2,3-a eckige klammer zu chinolizin-verbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
AT350526B (de) Verfahren zur herstellung von neuen 2-amino-1- phenylaethanolen -(1) und von deren salzen
DE2651750C2 (en))
JPH04368359A (ja) カプサイシン誘導体又はその酸エステルを有効成分とする鎮痛剤、血管拡張剤
DE2114230C2 (de) Verfahren zur Herstellung von 8-Methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino(3,2,1-j,k)carbazolhydrochlorid
EP0046144B1 (en) Therapeutically active derivatives of phenylethanol amines
NO129950B (en))
CS228114B2 (en) Production of novel derivatives of l-/4-hydroxyphenyl/-2-amino-ethanol
NO145656B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyletanolaminderivater
DE4411660A1 (de) Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
AT392968B (de) Neue xanthinderivate
KR840001050B1 (ko) 페닐알킬아민 유도체의 제조방법
DE1812770C (de) Saureadditionssalze des Racemats des 1 (3,4 Dihydroxyphenyl) 2 tert butyl aminobutanols (1) und dessen optischem 1R,2S Isomer
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
DE1545714C (de) 4 eckige Klammer auf 1 Benzylpipendyl (2) eckige Klammer zu 2,2 diphenyl 1,3 dioxolane und Verfahren zu ihrer Herstellung
Chappel et al. Pharmacological studies on new synthetic antitussive agents
DE2259615A1 (de) Bronchospasmolytisch wirksame verbindungen und verfahren zu deren herstellung
DE2108055A1 (de) Derivate von 2-Amino-imidazol-2-in und Verfahren zu deren Herstellung sowie diese Derivate enthaltende Medikamente